
Standard chemo response rates for LGSOC sit below 10%. A trial pairing a CDK4/6 inhibitor with hormone therapy hit 30.6% — the highest ever reported in this group.
Here's what that means, and what patients can access now. #OvarianCancer
nottheseovaries.org/cdk46-inhibito…



English













